R JOHN FLETCHER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for R JOHN FLETCHER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of R JOHN FLETCHER. R JOHN FLETCHER is Director in AUTOIMMUNE INC ($AIMM) and Director in SPECTRANETICS CORP ($SPNC) and Director in REPRO MED SYSTEMS INC ($REPR) and Director in AXCELIS TECHNOLOGIES INC ($ACLS) and Director in MRI INTERVENTIONS, INC. ($MRIC) and Director in Vyant Bio, Inc. ($CGIX).
Latest Insider Trading Transactions of R JOHN FLETCHER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIMM, ACLS, MRIC, KRMD, SPNC, CGIX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 12 2021 | MRIC | ClearPoint Neuro, ... | FLETCHER R JOHN | Director | Grant | A | 19.57 | 738 | 14,443 | 47,134 | 46.4 K to 47.1 K (+1.59 %) |
Apr 01 2021 | CGIX | Vyant Bio, Inc. | FLETCHER R JOHN | Director | Option Exercise | A | 4.61 | 13,015 | 59,999 | 13,015 | |
Apr 01 2021 | CGIX | Vyant Bio, Inc. | FLETCHER R JOHN | Director | Option Exercise | J | 1.56 | 10,265 | 16,013 | 10,265 | |
Apr 01 2021 | CGIX | Vyant Bio, Inc. | FLETCHER R JOHN | Director | Grant | A | 0.00 | 8,676 | 0 | 8,676 | 0 to 8.7 K |
Apr 01 2021 | CGIX | Vyant Bio, Inc. | FLETCHER R JOHN | Director | Option Exercise | A | 4.61 | 13,015 | 59,999 | 13,015 | |
Apr 01 2021 | CGIX | Vyant Bio, Inc. | FLETCHER R JOHN | Director | Option Exercise | J | 1.56 | 10,265 | 16,013 | 10,265 | |
Apr 01 2021 | CGIX | Vyant Bio, Inc. | FLETCHER R JOHN | Director | Grant | A | 0.00 | 8,676 | 0 | 8,676 | 0 to 8.7 K |
Feb 17 2021 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Sell | S | 39.00 | 6,881 | 268,359 | 1,354 | 8.2 K to 1.4 K (-83.56 %) |
Jan 04 2021 | KRMD | REPRO MED SYSTEMS ... | FLETCHER R JOHN | Director | Grant | A | 6.02 | 3,114 | 18,746 | 54,439 | 51.3 K to 54.4 K (+6.07 %) |
Jan 04 2021 | MRIC | ClearPoint Neuro, ... | FLETCHER R JOHN | Director | Grant | A | 15.00 | 808 | 12,120 | 46,396 | 45.6 K to 46.4 K (+1.77 %) |
Dec 01 2020 | KRMD | REPRO MED SYSTEMS ... | FLETCHER R JOHN | Director | Buy | P | 4.53 | 1,275 | 5,776 | 51,325 | 50.1 K to 51.3 K (+2.55 %) |
Dec 01 2020 | KRMD | REPRO MED SYSTEMS ... | FLETCHER R JOHN | Director | Buy | P | 4.48 | 21,052 | 94,313 | 50,050 | 29 K to 50.1 K (+72.60 %) |
Oct 02 2020 | KRMD | REPRO MED SYSTEMS ... | FLETCHER R JOHN | Director | Grant | A | 7.22 | 2,597 | 18,750 | 28,998 | 26.4 K to 29 K (+9.84 %) |
Oct 01 2020 | MRIC | ClearPoint Neuro, ... | FLETCHER R JOHN | Director | Grant | A | 5.71 | 2,124 | 12,128 | 45,588 | 43.5 K to 45.6 K (+4.89 %) |
Oct 01 2020 | MRIC | ClearPoint Neuro, ... | FLETCHER R JOHN | Director | Grant | A | 5.71 | 2,124 | 12,128 | 45,588 | 43.5 K to 45.6 K (+4.89 %) |
Jul 02 2020 | MRIC | ClearPoint Neuro, ... | FLETCHER R JOHN | Director | Grant | A | 3.55 | 3,411 | 12,109 | 43,464 | 40.1 K to 43.5 K (+8.52 %) |
Jul 01 2020 | KRMD | REPRO MED SYSTEMS ... | FLETCHER R JOHN | Director | Grant | A | 8.98 | 2,088 | 18,750 | 26,401 | 24.3 K to 26.4 K (+8.59 %) |
Jun 17 2020 | MRIC | ClearPoint Neuro, ... | FLETCHER R JOHN | Director | Option Exercise | A | 4.13 | 15,000 | 61,950 | 15,000 | |
May 29 2020 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Sell | S | 26.52 | 50,750 | 1,345,890 | 8,235 | 59 K to 8.2 K (-86.04 %) |
May 15 2020 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Grant | A | 0.00 | 6,881 | 0 | 58,985 | 52.1 K to 59 K (+13.21 %) |
Apr 02 2020 | MRIC | ClearPoint Neuro, ... | FLETCHER R JOHN | Director | Grant | A | 3.57 | 3,396 | 12,124 | 40,053 | 36.7 K to 40.1 K (+9.26 %) |
Apr 01 2020 | KRMD | REPRO MED SYSTEMS ... | FLETCHER R JOHN | Director | Grant | A | 7.50 | 2,500 | 18,750 | 24,313 | 21.8 K to 24.3 K (+11.46 %) |
Jan 02 2020 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Grant | A | 4.96 | 2,445 | 12,127 | 36,657 | 34.2 K to 36.7 K (+7.15 %) |
Jan 02 2020 | REPR | REPRO MED SYSTEMS ... | FLETCHER R JOHN | Director | Grant | A | 6.53 | 1,914 | 12,498 | 20,856 | 18.9 K to 20.9 K (+10.10 %) |
Jan 02 2020 | REPR | REPRO MED SYSTEMS ... | FLETCHER R JOHN | Director | Grant | A | 6.53 | 1,914 | 12,498 | 20,856 | 18.9 K to 20.9 K (+10.10 %) |
Dec 12 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Option Exercise | M | 7.20 | 10,000 | 72,000 | 0 | |
Dec 12 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Option Exercise | M | 6.40 | 10,000 | 64,000 | 0 | |
Dec 12 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Sell | S | 23.52 | 20,000 | 470,400 | 52,104 | 72.1 K to 52.1 K (-27.74 %) |
Dec 12 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Buy | M | 7.20 | 10,000 | 72,000 | 72,104 | 62.1 K to 72.1 K (+16.10 %) |
Dec 12 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Buy | M | 6.40 | 10,000 | 64,000 | 62,104 | 52.1 K to 62.1 K (+19.19 %) |
Dec 11 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Option Exercise | M | 7.96 | 10,000 | 79,600 | 0 | |
Dec 11 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Option Exercise | M | 6.40 | 12,500 | 80,000 | 0 | |
Dec 11 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Sell | S | 22.96 | 22,500 | 516,600 | 52,104 | 74.6 K to 52.1 K (-30.16 %) |
Dec 11 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Buy | M | 7.96 | 10,000 | 79,600 | 74,604 | 64.6 K to 74.6 K (+15.48 %) |
Dec 11 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Buy | M | 6.40 | 12,500 | 80,000 | 64,604 | 52.1 K to 64.6 K (+23.99 %) |
Oct 02 2019 | REPR | REPRO MED SYSTEMS ... | FLETCHER R JOHN | Director | Grant | A | 3.95 | 1,582 | 6,249 | 18,942 | 17.4 K to 18.9 K (+9.11 %) |
Oct 01 2019 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Grant | A | 5.15 | 2,355 | 12,128 | 34,212 | 31.9 K to 34.2 K (+7.39 %) |
Jul 02 2019 | REPR | REPRO MED SYSTEMS ... | FLETCHER R JOHN | Director | Grant | A | 2.88 | 1,312 | 3,779 | 17,360 | 16 K to 17.4 K (+8.18 %) |
Jul 01 2019 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Grant | A | 3.17 | 3,829 | 12,138 | 31,857 | 28 K to 31.9 K (+13.66 %) |
Jun 17 2019 | REPR | REPRO MED SYSTEMS ... | FLETCHER R JOHN | Director | Grant | A | 2.18 | 16,048 | 34,985 | 16,048 | 0 to 16 K |
Jun 10 2019 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Option Exercise | A | 3.25 | 15,000 | 48,750 | 15,000 | |
May 15 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Grant | A | 0.00 | 6,232 | 0 | 52,104 | 45.9 K to 52.1 K (+13.59 %) |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Option Exercise | M | 3.72 | 10,000 | 37,200 | 0 | |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Option Exercise | M | 3.72 | 10,000 | 37,200 | 0 | |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Option Exercise | M | 1.76 | 12,500 | 22,000 | 0 | |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Option Exercise | M | 1.76 | 12,500 | 22,000 | 0 | |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Sell | S | 20.27 | 10,000 | 202,700 | 45,872 | 55.9 K to 45.9 K (-17.90 %) |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Sell | S | 20.27 | 10,000 | 202,700 | 45,872 | 55.9 K to 45.9 K (-17.90 %) |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Buy | M | 3.72 | 10,000 | 37,200 | 55,872 | 45.9 K to 55.9 K (+21.80 %) |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Buy | M | 3.72 | 10,000 | 37,200 | 55,872 | 45.9 K to 55.9 K (+21.80 %) |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Sell | S | 20.26 | 12,500 | 253,250 | 45,872 | 58.4 K to 45.9 K (-21.41 %) |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Sell | S | 20.26 | 12,500 | 253,250 | 45,872 | 58.4 K to 45.9 K (-21.41 %) |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Buy | M | 1.76 | 12,500 | 22,000 | 58,372 | 45.9 K to 58.4 K (+27.25 %) |
Mar 13 2019 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Buy | M | 1.76 | 12,500 | 22,000 | 58,372 | 45.9 K to 58.4 K (+27.25 %) |
Jan 02 2019 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Grant | A | 1.47 | 8,248 | 12,125 | 24,174 | 15.9 K to 24.2 K (+51.79 %) |
Oct 01 2018 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Grant | A | 1.76 | 6,900 | 12,144 | 15,926 | 9 K to 15.9 K (+76.45 %) |
Oct 01 2018 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Grant | A | 1.76 | 6,900 | 12,144 | 15,926 | 9 K to 15.9 K (+76.45 %) |
Jul 03 2018 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Grant | A | 2.18 | 5,394 | 11,759 | 9,026 | 3.6 K to 9 K (+148.51 %) |
Jun 11 2018 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Option Exercise | A | 2.18 | 15,000 | 32,700 | 15,000 | |
May 17 2018 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Grant | A | 0.00 | 5,637 | 0 | 45,872 | 40.2 K to 45.9 K (+14.01 %) |
Apr 02 2018 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Grant | A | 3.13 | 3,632 | 11,368 | 3,632 | 0 to 3.6 K |
Apr 02 2018 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Grant | A | 3.13 | 3,632 | 11,368 | 3,632 | 0 to 3.6 K |
Dec 14 2017 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Option Exercise | A | 2.75 | 13,875 | 38,156 | 13,875 | |
Aug 11 2017 | SPNC | SPECTRANETICS CORP | FLETCHER R JOHN | Director | Sell | D | 38.50 | 141,697 | 5,455,335 | 0 | 141.7 K to 0 (-100.00 %) |
Jun 12 2017 | SPNC | SPECTRANETICS CORP | FLETCHER R JOHN | Director | Grant | A | 0.00 | 4,780 | 0 | 141,697 | 136.9 K to 141.7 K (+3.49 %) |
May 17 2017 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Grant | A | 0.00 | 3,802 | 0 | 40,235 | 36.4 K to 40.2 K (+10.44 %) |
May 11 2017 | MRIC | MRI INTERVENTIONS, ... | FLETCHER R JOHN | Director | Option Exercise | A | 6.40 | 1,125 | 7,200 | 1,125 | |
Jul 05 2016 | SPNC | SPECTRANETICS CORP | FLETCHER R JOHN | Director | Grant | A | 0.00 | 6,949 | 0 | 136,917 | 130 K to 136.9 K (+5.35 %) |
May 17 2016 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Grant | A | 0.00 | 30,545 | 0 | 145,730 | 115.2 K to 145.7 K (+26.52 %) |
Oct 29 2015 | SPNC | SPECTRANETICS CORP | FLETCHER R JOHN | Director | Buy | P | 12.04 | 8,240 | 99,201 | 129,968 | 121.7 K to 130 K (+6.77 %) |
Oct 26 2015 | SPNC | SPECTRANETICS CORP | FLETCHER R JOHN | Director | Buy | P | 12.41 | 8,000 | 99,297 | 121,728 | 113.7 K to 121.7 K (+7.03 %) |
Jul 16 2015 | ACLS | AXCELIS TECHNOLOGI ... | FLETCHER R JOHN | Director | Grant | A | 0.00 | 16,000 | 0 | 115,185 | 99.2 K to 115.2 K (+16.13 %) |
Jun 15 2015 | SPNC | SPECTRANETICS CORP | FLETCHER R JOHN | Director | Grant | A | 0.00 | 3,774 | 0 | 113,728 | 110 K to 113.7 K (+3.43 %) |
Mar 06 2015 | SPNC | SPECTRANETICS CORP | FLETCHER R JOHN | Director | Option Exercise | M | 5.31 | 45,000 | 238,950 | 0 | |
Mar 06 2015 | SPNC | SPECTRANETICS CORP | FLETCHER R JOHN | Director | Sell | S | 34.35 | 22,245 | 764,200 | 109,954 | 132.2 K to 110 K (-16.83 %) |
Mar 06 2015 | SPNC | SPECTRANETICS CORP | FLETCHER R JOHN | Director | Buy | M | 5.31 | 45,000 | 238,950 | 132,199 | 87.2 K to 132.2 K (+51.61 %) |
May 21 2004 | AIMM | AUTOIMMUNE INC | FLETCHER R JOHN | Director | Option Exercise | A | 1.10 | 1,000 | 1,100 | 91,000 |
Page: 1